Grupos

Home Grupo de investigación

GRUPOS DE INVESTIGACIÓN

País Vasco

arrow

Biosistemak - OSI Barrualde Galdakao

Risk factors for the development of in-hospital complications in pluripathological patients.

Jamal-Ismail Ortiz Y, García-Gutiérrez S, Renom-Guiteras A, Ternero-Vega JE, Legarreta-Olabarrieta MJ, Mestre D, Martín-Escalante MD, Quirós-López R, . Risk factors for the development of in-hospital complications in pluripathological patients.. Rev Clin Esp (Barc). 2026 Jun;:502595. doi:10.1016/j.rceng.2026.502595. Epub 2026 Jun 10. PMID:42269922.
Fecha: 2026

SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study of obeldesivir in high-risk nonhospitalized participants with COVID-19.

Hedskog C, Rodriguez L, Hu Y, Li J, Han D, Peinovich N, Martinez C, Ho PY, Perry JK, González Del Castillo JM, Koullias Y, Martin R, Hyland RH. SARS-CoV-2 resistance analyses from the Phase 3 BIRCH study of obeldesivir in high-risk nonhospitalized participants with COVID-19.. Antiviral Res. 2026 Mar;247:106351. doi:10.1016/j.antiviral.2026.106351. Epub 2026 Jan 19. PMID:41565160.
Fecha: 2026

Sex differences in HIV testing in Catalan emergency departments.

Robert N, Miró E, Llaneras J, Guardiola JM, Smithson A, Leey C, Bustamante MA, Ferro JI, Michelini M, Martínez A, Saura M, Viñas J, González Del Castillo J, Gené E, Miró Ò, . Sex differences in HIV testing in Catalan emergency departments.. Eur J Emerg Med. 2026 Feb;33:45. doi:10.1097/MEJ.0000000000001291. Epub 2025 Nov 17. PMID:41258674.
Fecha: 2026

Strengthening antimicrobial resistance governance in Europe: a coordinated one health approach.

Davido B, Ny S, van Lingen C, Årdal C, Alonso Irujo L, Linnros S, Collineau L, Gonzalez Hernandez N, Gutierrez Rubio M, van de Laar G, Politi L, Kristensen B, Álvarez-Fernández A, Lacotte Y, Claude A, Ploy MC, . Strengthening antimicrobial resistance governance in Europe: a coordinated one health approach.. Lancet Reg Health Eur. 2026 Feb;61:101540. doi:10.1016/j.lanepe.2025.101540. Epub 2025 Nov 18. pmc:PMC12767864. PMID:41498071.
Fecha: 2026

Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymaking.

Armocida B, Tolonen H, Rakovac I, Formenti B, Farrington J, Ekberg A, Bueno H, Capelli G, Francisci S, Frydensberg MS, Fullaondo A, Granlund L, Azcarate YH, Hansen TF, Høstrup E, Mäki-Opas T, Palmieri L, Peltonen M, Possenti V, Silano M, Weiler G, Wickramasinghe K, Wouters E, Klepp KI, Onder G, Galea G. Strengthening non-communicable diseases monitoring systems in Europe through a multistakeholder collaborative approach: a key priority for advancing data-driven policymaking.. Lancet Reg Health Eur. 2026 Feb;61:101553. doi:10.1016/j.lanepe.2025.101553. Epub 2025 Dec 11. pmc:PMC12756707. PMID:41488490.
Fecha: 2026

Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.

Mercadal-Orfila G, López Sánchez P, Padullés-Zamora N, Pou Alonso A, Ibarra-Barrueta O, Monte-Boquet E, Borrás Blasco J, Sanmartin-Fenollera P, Capilla Montes C, Bernabéu Martínez MA, Notario Rosa J, Escrivá Sancho ME, Herrera-Pérez S. Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.. Farm Hosp. 2026 Jun;:. doi:10.1016/j.farma.2026.04.009. Epub 2026 Jun 05. PMID:42248781.
Fecha: 2026

Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.

Mercadal-Orfila G, López Sánchez P, Padullés-Zamora N, Pou Alonso A, Ibarra-Barrueta O, Monte-Boquet E, Borrás Blasco J, Sanmartin-Fenollera P, Capilla Montes C, Bernabéu Martínez MA, Notario Rosa J, Escrivá Sancho ME, Herrera-Pérez S. Telepharmacy follow-up using electronic patient-reported outcome measures in moderate-to-severe psoriasis.. Farm Hosp. 2026 Mar;:. doi:10.1016/j.farma.2026.01.006. Epub 2026 Mar 26. PMID:41896043.
Fecha: 2026

Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study.

García-Aranda M, Martín-García D, Gallejones-Eskubi J, Urrechaga E, Ferreiro J, Portugal V, Portillo I, Jiménez-Toscano M, Legarreta MJ, Quintana JM, Redondo M, Aguirre U, . Ten-Year Outcomes in Colorectal Cancer-Competing Risks and Patient Vulnerability: A Prospective Multicenter Observational Study.. J Clin Med. 2026 Jun;15:. doi:10.3390/jcm15114389. Epub 2026 Jun 05. pmc:PMC13258410. PMID:42279250.
Fecha: 2026

Use of physical restraint measures in the internal medicine department of an acute care hospital.

Mellado Ferreiro M, Pertusa Martínez S, García Gutiérrez S, Legarreta Olabarrieta MJ. Use of physical restraint measures in the internal medicine department of an acute care hospital.. Med Clin (Barc). 2026 Jun;166:107432. doi:10.1016/j.medcli.2026.107432. Epub 2026 Apr 04. PMID:41936789.
Fecha: 2026

Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.

Privitera G, Bezzio C, Figlioli G, D'Amico F, Mendes J, Varca S, Zingone F, Rodriguez-Lago I, Onali S, Caprioli FA, Chaparro M, Barreiro-de-Acosta M, Karmiris K, Degabli NT, Dar L, Pastorelli L, Gutiérrez A, Orlando A, Zabana Y, Saibeni S, Piovani D, Savarino EV, Pugliese D, Magro F, Danese S, Armuzzi A, . Ustekinumab and Janus Kinase Inhibitors Outperform Vedolizumab as Second-line Therapy in Anti-tumor Necrosis Factor-experienced Patients With Ulcerative Colitis.. Clin Gastroenterol Hepatol. 2026 Jan;:. doi:10.1016/j.cgh.2026.01.017. Epub 2026 Jan 29. PMID:41616901.
Fecha: 2026

Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.

Ferreiro-Iglesias R, Hernández-Camba A, Valdivia A, Rodríguez-Lago I, Zabana Y, Barreiro-de Acosta M, . Vaccination recommendations and adherence in inflammatory bowel disease: A physician-patient discordance study.. Gastroenterol Hepatol. 2026 Mar;:502714. doi:10.1016/j.gastrohep.2026.502714. Epub 2026 Mar 02. PMID:41780635.
Fecha: 2026
© Ricapps 2026 | Desarrollado por VGS